Ana Catalina "Cata" Arce-Clachar, MD

Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes. Newton, KP; Jayasekera, D; Blackford, AL; Behling, C; Wilson, LA; Fishbein, MH; Molleston, JP; Xanthakos, SA; Vos, MB; Schwimmer, JB. Hepatology. 2025; 82(5):1198-1210.

Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease. Klein, J; Arce-Clachar, AC; Bramlage, K; Xanthakos, S; Sheridan, R; Mouzaki, M. Childhood Obesity. 2025; 21(6):544-548.

Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Kohut, T; Tou, A; Carr, E; Xanthakos, S; Arce-Clachar, AC; Fawaz, R; Valentino, PL; Panganiban, J; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2025; 49(3):308-313.

Least significant change with repeat bioelectrical impedance analysis measurements in children with metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2025; 49(2):200-206.

Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Ley, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. Journal of Pediatrics. 2025; 276:114301.

Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity. Mouzaki, M; Yates, KP; Arce-Clachar, AC; Behling, C; Blondet, NM; Fishbein, MH; Flores, F; Adams, KH; Hertel, P; Jain, AK; Molleston, JP; Schwimmer, JB; Vos, MB; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2024; 79(2):238-249.

Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Wang, A; Blackford, AL; Behling, C; Wilson, LA; Newton, KP; Xanthakos, SA; Fishbein, MH; Vos, MB; Mouzaki, M; Molleston, JP; Jain, AK; Hertel, P; Harlow Adams, K; Schwimmer, JB. Hepatology. 2024; 79(6):1381-1392.

Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Zhao, X; Setchell, KDR; Carr, E; Arce-Clachar, AC; Bramlage, K; Huang, R; Fei, L; Beck, AF; Fawaz, R; Valentino, PL; Xanthakos, SA; Mouzaki, M. Journal of Pediatrics. 2024; 265:113818.

Nutrition assessment and MASH severity in children using the Healthy Eating Index. Jain, AK; Buchannan, P; Yates, KP; Belt, P; Schwimmer, JB; Rosenthal, P; Murray, KF; Molleston, JP; Scheimann, A; Xanthakos, SA; Nilson, J; Neuschwander-Tetri, BA; Tonascia, J; Vos, MB. Hepatology Communications. 2023; 7(12).

Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease. P V Alves, V; T Trout, A; Dewit, M; Mouzaki, M; Arce-Clachar, AC; S Bramlage, K; R Dillman, J; A Xanthakos, S. Childhood Obesity. 2023; 19(7):461-469.